Gene · 51330
Papers2,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor Necrosis Factor Receptor Superfamily Member 12A Enhances Retinal Ganglion Cell Survival and Promotes Axon Regeneration. | FASEB J | 2025 | 40747811 | PubTator, text mining | PubMed |
| Exploring the therapeutic potential of H1-antihistamines in endometriosis-A gene regulation-based perspective. | Front Med (Lausanne) | 2025 | 40747097 | PubTator, text mining | PubMed |
| Outcomes of Ultimpro Testing Implementation for Patients With Unexplained Recurrent Implantation Failure: A Single-Center Retrospective Cohort Study. | Am J Reprod Immunol | 2025 | 40742048 | PubTator, text mining | PubMed |
| Kirenol relieves rheumatoid arthritis by targeting the TWEAK/Fn14 pathway. | Int J Mol Med | 2025 | 40682832 | PubTator, text mining | PubMed |
| Human PXR Signaling Exacerbates Ethanol-induced Liver Injury in Females: Evidence From Mouse Models and Human Alcohol-associated Liver Disease Cohorts. | Cell Mol Gastroenterol Hepatol | 2025 | 40681042 | PubTator, text mining | PubMed |
| High expression of the cachexia-related protein Fn14 in esophageal squamous cell carcinoma correlates with poor chemotherapy response and anti-Fn14 therapy decreases chemotherapeutic resistance. | Br J Cancer | 2025 | 40665013 | PubTator, text mining | PubMed |
| TWEAK/Fn14 Drives Tumor Progression and Is Associated With Poor Survival of Colorectal Liver Metastases With Replacement Growth Patterns. | Cancer Med | 2025 | 40629930 | PubTator, text mining | PubMed |
| TWEAK/Fn14 hypomethylation and higher plasma TWEAK and TNF-α levels are related to sarcopenic obesity in community-dwelling elderly in Xinjiang. | Medicine (Baltimore) | 2025 | 40629651 | PubTator, text mining | PubMed |
| Fn14-Targeted Gold Nanorods for Augmenting Laser Thermal Therapy for High-Grade Gliomas. | Langmuir | 2025 | 40625198 | PubTator, text mining | PubMed |
| Potential role of TNFRSF12A in linking glioblastoma and alzheimer's disease via shared tumour suppressor pathways. | Sci Rep | 2025 | 40595248 | PubTator, text mining | PubMed |
| Multi-Omics Identification of Fos as a Central Regulator in Skeletal Muscle Adaptation to Long-Term Aerobic Exercise. | Biology (Basel) | 2025 | 40563849 | PubTator, text mining | PubMed |
| Urinary TWEAK reflects disease activity in ANCA-associated vasculitis. | Clin Kidney J | 2025 | 40443963 | PubTator, text mining | PubMed |
| TNFRSF12A expression in stomach adenocarcinoma and its preliminary role in predicting immunotherapy response. | Front Immunol | 2025 | 40391219 | PubTator, text mining | PubMed |
| Identification and verification of a polyamine metabolism-related gene signature for predicting prognosis and immune infiltration in osteosarcoma. | J Orthop Surg Res | 2025 | 40383808 | PubTator, text mining | PubMed |
| Single-cell analyses unravel ecosystem dynamics and intercellular crosstalk during gallbladder cancer malignant transformation. | Hepatol Commun | 2025 | 40377484 | PubTator, text mining | PubMed |
| TIGIT deficiency promotes autoreactive CD4+ T-cell responses through a metabolic‒epigenetic mechanism in autoimmune myositis. | Nat Commun | 2025 | 40374622 | PubTator, text mining | PubMed |
| Autoimmune bullous diseases: pathogenesis and clinical management. | Mol Biomed | 2025 | 40372624 | PubTator, text mining | PubMed |
| Elaboration and verification of immune-based diagnostic biomarker panel for diabetic foot ulcer. | J Diabetes Complications | 2025 | 40349610 | PubTator, text mining | PubMed |
| Fn14 Controls the SIRT2-Mediated Deacetylation of Slug to Inhibit the Metastasis of Epithelial Ovarian Cancer. | Adv Sci (Weinh) | 2025 | 40344622 | PubTator, text mining | PubMed |
| Exploring the Role of Inflammation and Metabolites in Bell's Palsy and Potential Treatment Strategies. | Biomedicines | 2025 | 40299566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51330/papers?page=5